Cellosaurus logo
expasy logo
Due to maintenance work, this service will be unavailable from Mon Nov 11 17:30 until Tue Nov 12 09:00 CET. Apologies for the inconvenience.

Cellosaurus CC-SW-1 (CVCL_A429)

[Text version]
Cell line name CC-SW-1
Synonyms CC-SW-I; CCSW-1; CCSW1
Accession CVCL_A429
Resource Identification Initiative To cite this cell line use: CC-SW-1 (RRID:CVCL_A429)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Population: Caucasian.
Doubling time: 72 hours (PubMed=1355757).
Derived from site: In situ; Liver; UBERON=UBERON_0002107.
Disease Intrahepatic cholangiocarcinoma (NCIt: C35417)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 55Y
Category Cancer cell line
STR profile Source(s): DepMap=ACH-001960

Markers:
AmelogeninX
CSF1PO10,14
D3S135814
D5S81811,14
D7S82011,12
D8S117912,13
D13S31710,11
D16S53911,12
D18S5116
D21S1129,30
FGA22,23
Penta D10,11
Penta E12,16
TH019,9.3
TPOX6,8
vWA13,17

Run an STR similarity search on this cell line
Publications

PubMed=1355757; DOI=10.1002/ijc.2910520217
Shimizu Y., Demetris A.J., Gollin S.M., Storto P.D., Bedford H.M., Altarac S., Iwatsuki S., Herberman R.B., Whiteside T.L.
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
Int. J. Cancer 52:252-260(1992)

CLPUB00275
Zach S., Birgin E., Ruckert F.
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442; PMCID=PMC5458737
Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C., Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K., Greninger P., McDermott U., Garnett M.J., Jenkins R.L., Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y., Goyal L., Ferrone C.R., Zhu A.X.-X., Joung J.K., Shokat K.M., Benes C.H., El-Bardeesy N.
Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.
Cancer Discov. 6:727-739(2016)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

Cross-references
Cell line databases/resources cancercelllines; CVCL_A429
Cell_Model_Passport; SIDM01888
DepMap; ACH-001960
Encyclopedic resources Wikidata; Q54808718
Polymorphism and mutation databases Cosmic; 927188
Entry history
Entry creation06-Jun-2012
Last entry update02-May-2024
Version number18